1003-3734
2016 Issue 5
..............page:476
Pharmacological and clinical evaluation of brexpiprazole in the treatment of schizophrenia and major depressive disorder
XU Lei;FENG Yu-fei;Shenyang Pharmaceutical University;Department of Pharmacy;Beijing Hospital;
XU Lei;FENG Yu-fei;Shenyang Pharmaceutical University;Department of Pharmacy;Beijing Hospital;
..............page:481-483+511
Histone deacetylase inhibitors and related patent information
QIAN Li-na;ZHANG Chang-chun;HUANG Lu;Waterstone Pharmaceuticals Co.;Ltd.;Wuhan National Bioindustry Innovation Park Management Co.;Ltd.;Humanwell Healthcare Co.;Ltd.;
QIAN Li-na;ZHANG Chang-chun;HUANG Lu;Waterstone Pharmaceuticals Co.;Ltd.;Wuhan National Bioindustry Innovation Park Management Co.;Ltd.;Humanwell Healthcare Co.;Ltd.;
..............page:484-489+517
Novelty of polymorphic drug patents
ZHANG Hui;MA Qiu-juan;DENG Sheng-ju;Patent Examination Cooperation Center of the Patent Office;Guo Zhi Patent Warning Consulting Center;
ZHANG Hui;MA Qiu-juan;DENG Sheng-ju;Patent Examination Cooperation Center of the Patent Office;Guo Zhi Patent Warning Consulting Center;
..............page:490-494
Application of quality risk management in the production of large volume injections
ZHENG Hui-hui;HUANG Yan-peng;WANG Qing-fen;ZHANG Rong;The 175th Hospital of PLA Affiliated Dongnan Hospital of Xiamen University;
ZHENG Hui-hui;HUANG Yan-peng;WANG Qing-fen;ZHANG Rong;The 175th Hospital of PLA Affiliated Dongnan Hospital of Xiamen University;
..............page:495-498
General consideration for the environmental risk assessment for genetically modified live attenuated vaccines
CHEN Qing-hua;LI Min;LUO Jian-hui;GAO En-ming;Center for Drug Evaluation;China Food and Drug Administration;
CHEN Qing-hua;LI Min;LUO Jian-hui;GAO En-ming;Center for Drug Evaluation;China Food and Drug Administration;
..............page:499-502
Toxicity of retagliptin phosphate in beagle dogs following repeated gavage administration
ZHOU Xiao-bing;ZHANG Lin;ZHANG Lian-shan;SUN Li;MIAO Yu-fa;LI Shan-shan;LIU Fang;YANG Yan-wei;WANG Ju-feng;LI Bo;National Center for Safety Evaluation of Drugs;National Institutes for Food and Drug Control;Jiang Su Heng Rui Medicine Co.;Ltd.;
ZHOU Xiao-bing;ZHANG Lin;ZHANG Lian-shan;SUN Li;MIAO Yu-fa;LI Shan-shan;LIU Fang;YANG Yan-wei;WANG Ju-feng;LI Bo;National Center for Safety Evaluation of Drugs;National Institutes for Food and Drug Control;Jiang Su Heng Rui Medicine Co.;Ltd.;
..............page:503-507
Study on water-extractionprocess for Xuanbi’antong prescription
REN Wei-guang;WANG Jie;ZHANG Cui-ying;CHEN Heng-wen;WEI Ben-jun;HUANG Shi-jing;Guang’anmen Hospital;China Academy of Chinese Medical Science;
REN Wei-guang;WANG Jie;ZHANG Cui-ying;CHEN Heng-wen;WEI Ben-jun;HUANG Shi-jing;Guang’anmen Hospital;China Academy of Chinese Medical Science;
..............page:508-511
Progress in researches on personalized medicine of oral solid preparations
CHEN Lu;SHAO Shuai;GAO Chun-sheng;Institute of Pharmacology and Toxicology;Academy of Military Medical Science;
CHEN Lu;SHAO Shuai;GAO Chun-sheng;Institute of Pharmacology and Toxicology;Academy of Military Medical Science;
..............page:512-517
Progress in research of bispecific antibody drugs
GUO Ting-ting;LIANG Jin-feng;NIE Lei;WANG Hai-bin;BAI Hua;Zhejiang Hisun Pharmaceutical Co.;Ltd.;Zhejiang Center for Drug and Cosmetic Evaluation;
GUO Ting-ting;LIANG Jin-feng;NIE Lei;WANG Hai-bin;BAI Hua;Zhejiang Hisun Pharmaceutical Co.;Ltd.;Zhejiang Center for Drug and Cosmetic Evaluation;
..............page:518-523
Establishing statistically sound sampling plan and corresponding acceptance criteria for content uniformity standard in the Chinese pharmacopoeia
MA Qian;DAI Jun-hao;ZHENG Qiang;Center for Pharmaceutical Information and Engineering Research;Department of Industrial Engineering and Management;College of Engineering;Peking University;
MA Qian;DAI Jun-hao;ZHENG Qiang;Center for Pharmaceutical Information and Engineering Research;Department of Industrial Engineering and Management;College of Engineering;Peking University;
..............page:524-531
Biowaiver for immediate-release solid oral dosage forms based on biopharmaceutics classification system
LIU Man;ZHANG Wen-ping;ZHANG Li-na;LIU Hui-chen;Department of Clinical Pharmacology;Aerospace Center Hospital;Institute of Clinical Pharmacology;Department of Pharmacy;General Hospital of Ningxia Medical University;No.804 Shengli Street;
LIU Man;ZHANG Wen-ping;ZHANG Li-na;LIU Hui-chen;Department of Clinical Pharmacology;Aerospace Center Hospital;Institute of Clinical Pharmacology;Department of Pharmacy;General Hospital of Ningxia Medical University;No.804 Shengli Street;
..............page:532-542+588
Prospect of application of minipigs in drug safety evaluation
DING Yan-wei;ZHOU Da-peng;SHI Cheng-kong;WU Yong-qian;PENG Peng;Xuanzhu Pharm Co.;Ltd.;
DING Yan-wei;ZHOU Da-peng;SHI Cheng-kong;WU Yong-qian;PENG Peng;Xuanzhu Pharm Co.;Ltd.;
..............page:543-547
Current status of polymer nanoparticles drug delivery system
JIN Guang-ming;JIN Ming-ji;YIN Xue-zhe;GAO Zhong-gao;State Key Laboratory of Bioactive Substances and Functions of Natural Medicines;Institut of Materia Medica;Chinese Academy of Medical Sciences & Peking Union Medical College;Yanbian University Affiliated Hospital;
JIN Guang-ming;JIN Ming-ji;YIN Xue-zhe;GAO Zhong-gao;State Key Laboratory of Bioactive Substances and Functions of Natural Medicines;Institut of Materia Medica;Chinese Academy of Medical Sciences & Peking Union Medical College;Yanbian University Affiliated Hospital;
..............page:548-553
Drugs beyond stains for management of familial hypercholesterolemia
WANG Jie;LUN Yu;JING Zhao-hai;YANG Guang-hui;WANG Yan-gang;Department of Endocrinology;the Affiliated Hospital of Qingdao University;
WANG Jie;LUN Yu;JING Zhao-hai;YANG Guang-hui;WANG Yan-gang;Department of Endocrinology;the Affiliated Hospital of Qingdao University;
..............page:554-557+568
Dezocine combined with low-dose naloxone for postoperative analgesia in radical thyroidectomy
LI Zhi-hong;WANG Li-ping;HE Zi-jing;Key laboratory of Carcinogenesis and Translational Research;Department of Anesthesiology;Peking University Cancer Hospital & Institute;
LI Zhi-hong;WANG Li-ping;HE Zi-jing;Key laboratory of Carcinogenesis and Translational Research;Department of Anesthesiology;Peking University Cancer Hospital & Institute;
..............page:558-561
Pharmacokinetics and bioequivalence study of Sanqi-Tongshu Capsules in healthy Chinese volunteers
MA Ru-jun;ZHANG Xi-qian;YANG Hua-rong;JIANG Xue-hua;West China School of Pharmacy;Sichuan University;Pharmaceutical Factory of Chendu Huasun Group Inc.Ltd;
MA Ru-jun;ZHANG Xi-qian;YANG Hua-rong;JIANG Xue-hua;West China School of Pharmacy;Sichuan University;Pharmaceutical Factory of Chendu Huasun Group Inc.Ltd;
..............page:562-568
Dose-effect relationship of aripiprazole on hyperprolactinemia induced by risperidone in female patients
CHEN Hong-mei;ZHANG Rong-zhen;CHEN Jing-xu;LIU Yan-hong;LI Wei;TAN Yun-long;YANG Fu-de;Beijing Huilongguan Hospital;Peking University Hui Long Guan Clinical Medical School;
CHEN Hong-mei;ZHANG Rong-zhen;CHEN Jing-xu;LIU Yan-hong;LI Wei;TAN Yun-long;YANG Fu-de;Beijing Huilongguan Hospital;Peking University Hui Long Guan Clinical Medical School;
..............page:569-573
..............page:573
Effect of nateglinide on pharmacokinetics of rivaroxaban in rats
CUI Wen-ning;WANG Shu-mei;LIU Xiu-ju;YANG Xiu-ling;ZHANG Zhi-qing;LI De-qiang;The Second Hospital of Hebei Medical University;The Hospitol of Gucheng Conuty;
CUI Wen-ning;WANG Shu-mei;LIU Xiu-ju;YANG Xiu-ling;ZHANG Zhi-qing;LI De-qiang;The Second Hospital of Hebei Medical University;The Hospitol of Gucheng Conuty;
..............page:574-577+582
Application of tert-butyl alcohol in preparation of poorly-soluble drug bortezomib
XU Huan-huan;WANG Xiu-li;HE Cheng;PENG Chen;School of Chinese Pharmacy;Beijing University of Chinese Medicine;Center of Scientific Experiment;Beijing University of Chinese Medicine;Merck Chemicals Co.;Ltd.;
XU Huan-huan;WANG Xiu-li;HE Cheng;PENG Chen;School of Chinese Pharmacy;Beijing University of Chinese Medicine;Center of Scientific Experiment;Beijing University of Chinese Medicine;Merck Chemicals Co.;Ltd.;
..............page:578-582
Development of an ELISA for screening anti-conbercept antibody
BAI Hao;WEN Bo-xi;ZHU Wen-li;KE Xiao;Chengdu Kanghong Biotechnology Co.;Ltd.;
BAI Hao;WEN Bo-xi;ZHU Wen-li;KE Xiao;Chengdu Kanghong Biotechnology Co.;Ltd.;
..............page:583-588
Therapeutic effects of osthole in mice following stab wound injury
TAO Zhen-yu;KONG Liang;YAO Ying-jia;JIAO Ya-nan;LI Shao-heng;YAN Yu-hui;YANG Jing-xian;School of Pharmacy;Liaoning Unversity of Traditional Chinese Medicine;
TAO Zhen-yu;KONG Liang;YAO Ying-jia;JIAO Ya-nan;LI Shao-heng;YAN Yu-hui;YANG Jing-xian;School of Pharmacy;Liaoning Unversity of Traditional Chinese Medicine;
..............page:589-593+600
Analysis of gastrointestinal perforation induced by bevacizumab based on literature
CHENG Jun;Pharmaceutical Affair Office;the Third People’s Hospital of Bengbu;
CHENG Jun;Pharmaceutical Affair Office;the Third People’s Hospital of Bengbu;
..............page:594-596
Successful diagnosis and treatment of a patient with refractory insulin allergy
SUN Ying-hao;LI Jia-pei;LI Nai-shi;ZHAO Wei-gang;Key Laboratory of Endocrinology of Ministry of Health;Department of Endocrinology;Peking Union Medical College Hospital;PUMC and CAMS;
SUN Ying-hao;LI Jia-pei;LI Nai-shi;ZHAO Wei-gang;Key Laboratory of Endocrinology of Ministry of Health;Department of Endocrinology;Peking Union Medical College Hospital;PUMC and CAMS;
..............page:597-600